Calcifediol CAS 19356-17-3

Calcifediol Typical Properties

Items
Specifications
Results

Appearance
White powder
White powder

Identification (by IR)
Conforms to the GRS spectrum
+91.4°

Loss on drying
≤0.5%
0.2%

Sulphated ash
≤0.1%
0.09%

Assay(by HPLC)
97.0%~103.0%
99.7%

Related substances (by HPLC)
Any individual impurity ≤1.5%
0.28%

Total impurities≤ 2.0%
0.62%

Residual solvents
Ethanol≤5000ppm
Methylene chloride ≤600ppm
Hexane ≤290ppm
Dioxane ≤380ppm
Pyridine ≤200ppm
69ppm
43ppm
Undetected (LOD 3ppm)
Undetected(LOD 8pppm)
Undetected (LOD 4ppm)

Conclusion:   meet the specification according to USP31.

Calcifediol Usage
Treatment of various chronic bone disorders, and metabolic bone disease associated with chronic renal failure, hypocalcemia.
Osteosized diol can promote the absorption of Ca2 +, pi in the small intestine, increase the concentration of serum Ca2 +, pi, reduce the levels of alkaline phosphatase and parathyroid hormone in some patients, and reduce the mineral deficiency of some patients. Treatment and prevention of metabolic bone disease and kidney disease, renal dialysis in patients with chronic renal failure hypocalcemia, lack of rickets, various types of male rickets, osteoporosis, anticonvulsants caused by bone Loose and so have a good effect.
Calcifediol Packaging and Shipping
Packaging:25kg/drum or according to customer’s requiement
Shipping:It can be according to the customer’s request
Calcifediol Storage
Normal temperature preservation